Ligand-based virtual screen for the discovery of novel M5 inhibitor chemotypes von Geanes, Alexander R., Cho, Hykeyung P., Nance, Kellie D., McGowan, Kevin M., Conn, P. Jeffrey, Jones, Carrie K., Meiler, Jens, Lindsley, Craig W.

Volltext

Continued optimization of the M 5 NAM ML375: Discovery of VU6008667, an M 5 NAM with high CNS penetration and a desired short half-life in rat for addiction studies von McGowan, Kevin M, Nance, Kellie D, Cho, Hykeyung P, Bridges, Thomas M, Conn, P Jeffrey, Jones, Carrie K, Lindsley, Craig W

Volltext

Continued optimization of the M5 NAM ML375: Discovery of VU6008667, an M5 NAM with high CNS penetration and a desired short half-life in rat for addiction studies von McGowan, Kevin M., Nance, Kellie D., Cho, Hykeyung P., Bridges, Thomas M., Conn, P. Jeffrey, Jones, Carrie K., Lindsley, Craig W.

Volltext

Further optimization of the M1 PAM VU0453595: Discovery of novel heterobicyclic core motifs with improved CNS penetration von Panarese, Joseph D., Cho, Hykeyung P., Adams, Jeffrey J., Nance, Kellie D., Garcia-Barrantes, Pedro M., Chang, Sichen, Morrison, Ryan D., Blobaum, Anna L., Niswender, Colleen M., Stauffer, Shaun R., Conn, P. Jeffrey, Lindsley, Craig W.

Volltext

Ligand-based virtual screen for the discovery of novel M sub(5) inhibitor chemotypes von Geanes, Alexander R, Cho, Hykeyung P, Nance, Kellie D, McGowan, Kevin M, Conn, PJeffrey, Jones, Carrie K, Meiler, Jens, Lindsley, Craig W

Volltext